Pancreatic SPOREs

Pancreatic cancer is the 5th leading cause of cancer death in the United States. Over 33,000 newly diagnosed cases, and an estimated 32,300 deaths are expected in the United States in the year 2006. Presently, surgery, radiation and chemotherapies are treatment options that can extend survival and/or relieve symptoms in these patients, but seldom produce a cure. Patients with cancers of the pancreas have a particularly poor prognosis, as mortality from of this cancer is extremely high (5-year survival rate is about 4%). The pancreatic cancer SPORE program was initiated in the year 2002 and three SPOREs (one P50 and two P20) are awarded. Currently, the investigators from pancreatic cancer SPOREs are working closely with the researchers in GI Cancer SPOREs.

Mayo Clinic, Rochester

Gloria Petersen, PhD [Click Here]
Professor of Epidemiology
Mayo Clinic Rochester
Department of Health Sciences Research
200 First Street Southwest
Rochester, MN 55905
Tel: (507) 538-1563
Fax: (507) 266-2478
Email: petersen.gloria@mayo.edu

For more information on this specific SPORE’s institution, please visit:
http://mayoresearch.mayo.edu/mayo/research/gastro_cancer/

University of Alabama at Birmingham

Donald J. Buchsbaum, PhD [Click Here]
Professor and P.I.
UAB Pancreatic SPORE Program
Department of Radiation Oncology
Division of Radiology Biology
University of Alabama at Birmingham
1530 3rd Avenue South, SHEL 701
Birmingham, AL 35294
Tel: (205) 934-7077
Fax: (205) 975-7060
Email: donald.buchsbaum@ccc.uab.edu

For more information on this specific SPORE’s institution, please visit:
www.uab.edu/ccc/pancreaticcancer

University of Nebraska Medical Center

Michael A. Hollingsworth, PhD [Click Here]
Professor
University of Nebraska Medical Center
Eppley Institute for Cancer Research
985950 Nebraska Medical Center
Omaha, NE 68198
Tel: (402) 559-8343
Fax: (402) 559-2813
Email: mahollin@unmc.edu

For more information on this specific SPORE’s institution, please visit:
http://www.unmc.edu/eppley/spore